Valerie J Cicerone Bossard, MD | |
8001 Roosevelt Blvd, Suite 500, Philadelphi, PA 19152 | |
(215) 332-8870 | |
(215) 332-0810 |
Full Name | Valerie J Cicerone Bossard |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology - Gynecology |
Location | 8001 Roosevelt Blvd, Philadelphi, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003919507 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VG0400X | Obstetrics & Gynecology - Gynecology | MD022661E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Valerie J Cicerone Bossard, MD 8001 Roosevelt Blvd, Suite 500, Philadelphi, PA 19152 Ph: (215) 332-8870 | Valerie J Cicerone Bossard, MD 8001 Roosevelt Blvd, Suite 500, Philadelphi, PA 19152 Ph: (215) 332-8870 |
News Archive
Repeated courses of a drug that is used to improve the survival of unborn premature babies also may increase the risk of cerebral palsy in those children, according to results from a multi-center study, funded by the National Institutes of Health and led by Ronald Wapner, M.D., professor of obstetrics and gynecology, Columbia University Medical Center and attending obstetrician and gynecologist at NewYork-Presbyterian Hospital/Columbia.
Primary care physicians agree they have a role in addressing obesity, but say they do not have the right weight management resources. Obese or heavier adults take responsibility for weight loss, but adults who need to lose weight may lack information about effective weight loss methods and strategies. These findings and others come from new research commissioned and released today by the Strategies to Overcome and Prevent Obesity Alliance.
BSD Medical Corporation (NASDAQ:BSDM) (the "Company" or "BSD") announced today that a U.S. Government medical facility has purchased a BSD-500 Hyperthermia System (BSD-500).
When patients are prescribed opioids in risky ways, their chance of dying increases and their odds of death go higher as the number of risky opioid prescriptions increase, according to a new RAND Corporation study.
› Verified 2 days ago